Context Therapeutics Stock Price on October 18, 2024
| CNTX Stock | USD 1.52 0.02 1.33% |
If you're considering investing in Context Stock, it is important to understand the factors that can impact its price. As of today, the current price of Context Therapeutics stands at 1.52, as last reported on the 2nd of December, with the highest price reaching 1.55 and the lowest price hitting 1.50 during the day. Context Therapeutics secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13% return per unit of risk over the last 3 months. Context Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Context Therapeutics' Mean Deviation of 3.36, standard deviation of 4.68, and Risk Adjusted Performance of (0.09) to double-check the risk estimate we provide.
At this time, Context Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 83.9 M in 2024, whereas Preferred Stock Total Equity is likely to drop slightly above 130.1 M in 2024. . At this time, Context Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 1.60 in 2024, whereas Price Earnings Ratio is likely to drop (0.79) in 2024. Context Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Context |
Sharpe Ratio = -0.1334
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CNTX |
Estimated Market Risk
| 4.75 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.63 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Context Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Context Therapeutics by adding Context Therapeutics to a well-diversified portfolio.
Price Book 1.3594 | Book Value 0.744 | Enterprise Value 29.4 M | Enterprise Value Ebitda 1.5966 | Shares Float 39.1 M |
Related Headline
Spero Therapeutics Headline on 18th of October 2024
Critical Survey Synlogic Spero Therapeutics by thelincolnianonline.com
Spero Therapeutics and Synlogic are both small-cap medical companies, but which is the better business We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, institutional ownership, valuation and profitability. Profitability This table compares Spero Therapeutics and Synlogics
Context Therapeutics Valuation on October 18, 2024
It is possible to determine the worth of Context Therapeutics on a given historical date. On October 18, 2024 Context was worth 2.01 at the beginning of the trading date compared to the closed value of 2.04. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Context Therapeutics stock. Still, in general, we apply an absolute valuation method to find Context Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Context Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Context Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.02 | 2.09 | 1.98 | 2.01 | 83,776 | |
10/18/2024 | 2.01 | 2.06 | 1.97 | 2.04 | 36,499 |
| 2.06 | 2.08 | 2.03 | 2.06 | 49,277 |
| Backtest Context Therapeutics | | | Context Therapeutics History | | | Context Therapeutics Valuation | Previous | Next |
Context Therapeutics Trading Date Momentum on October 18, 2024
| On October 21 2024 Context Therapeutics was traded for 2.06 at the closing time. The top price for the day was 2.08 and the lowest listed price was 2.03 . The trading volume for the day was 49.3 K. The trading history from October 21, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 0.98% . The overall trading delta against the current closing price is 17.65% . |
Context Therapeutics Fundamentals Correlations and Trends
By evaluating Context Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Context Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Context financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Context Therapeutics Stock history
Context Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Context is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Context Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Context Therapeutics stock prices may prove useful in developing a viable investing in Context Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 18.4 M | 15.4 M | |
| Net Loss | -12 M | -12.6 M |
Context Therapeutics Stock Technical Analysis
Context Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Context Therapeutics Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Context Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Context Therapeutics December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Context Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Context Therapeutics shares will generate the highest return on investment. By undertsting and applying Context Therapeutics stock market strength indicators, traders can identify Context Therapeutics entry and exit signals to maximize returns
Context Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Context Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Context Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Context to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (1.41) | |||
| Treynor Ratio | (1.27) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Context Stock Analysis
When running Context Therapeutics' price analysis, check to measure Context Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Context Therapeutics is operating at the current time. Most of Context Therapeutics' value examination focuses on studying past and present price action to predict the probability of Context Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Context Therapeutics' price. Additionally, you may evaluate how the addition of Context Therapeutics to your portfolios can decrease your overall portfolio volatility.